Unknown NA INTERVENTIONAL 1-arm NCT03801590

Crosslinking in Infectious Keratitis

Safety and Efficacy Of Corneal Collagen Crosslinking (CXL) In Infectious Keratitis

Sponsor: Assiut University

Interventions Crosslinking with Riboflavin and UV-A

Updated 7 times since 2019 Last updated: Jul 19, 2021 Started: Dec 1, 2021 Primary completion: Jan 1, 2022 Completion: Jan 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03801590, this NA trial focuses on Infectious Keratitis and remains ongoing. Sponsored by Assiut University, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Aug 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Sep 2021 — Aug 2023 [monthly]

Not Yet Recruiting NA
Jan 2021 — Sep 2021 [monthly]

Not Yet Recruiting NA

▶ Show 2 earlier versions

Aug 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA
Feb 2019 — Aug 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.